Summary of Purpose
To assess the effect of ticlopidine in reducing the rate of subsequent occurrence of stroke, myocardial infarction, or vascular death in patients who have had a recent thromboembolic stroke.Read More →
The following dates are available for this trial. Trial information last updated on 8 March 2001.
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Syntex Research Inc., and Sanofi, France
Randomized, double-blind, placebo-controlled trial of 1072 patients at 25 centers.